President Donald Trump has signed a significant executive order directing Robert F. Kennedy Jr.’s MAHA Commission to harness artificial intelligence in the pursuit of breakthroughs in the treatment of childhood cancers. The move underscores the administration’s commitment to utilizing technological innovation to tackle pressing public health issues. The order aims to improve the identification and treatment of pediatric cancers through advanced AI technologies, signaling a strategic focus on leveraging cutting-edge solutions for health challenges.
In addition to this, Elon Musk’s AI company, xAI, is expanding its operations to include video game development by hiring game designers, marking a new direction for the company. Concurrently, the AI market is projected to reach a $29 trillion valuation by the end of the year, highlighting its rapid growth potential. This growth is further evidenced by the doubling of AI intelligence every six months, according to Constellation Research founder Ray Wang.
The integration of AI is also evident in practical applications, such as the use of autonomous lawnmowers on the National Mall in Washington, D.C., as part of the Trump administration’s initiative to enhance operational efficiency. Moreover, a New Jersey school district has adopted AI gun detection systems to identify potential threats and improve safety measures. Despite these advancements, the use of AI has raised ethical concerns, including the creation of synthetic performers like the artificial actress ‘Tilly Norwood’ and the potential for AI to alert authorities about suicidal intentions through platforms like ChatGPT.